文献速递静脉血栓栓塞

他汀治疗与深静脉血栓患者血栓溶解改善相关

Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2019-01-16

本研究回顾性分析818例下肢深静脉血栓患者,比较他汀组与非他汀组,发现两组在血栓溶解、死亡率或复发率上无差异,但多变量分析显示他汀治疗与血栓溶解或改善独立相关,且他汀未改变VTE复发或死亡等临床结局。

要点

  • 他汀治疗与DVT患者血栓溶解或改善独立相关。
  • 他汀组与非他汀组在血栓溶解、死亡率或VTE复发上无显著差异。
  • 他汀治疗未与VTE复发或死亡等临床结局差异相关。

核心结论

  • 他汀治疗与DVT患者血栓溶解或改善相关,但未与VTE复发或死亡率差异相关。

研究设计与样本

  • 回顾性研究纳入连续成人下肢DVT患者818例,他汀组279例(34%),非他汀组539例(66%)。

主要发现

  • 他汀组患者年龄更大(P < .001),更常合并动脉粥样硬化危险因素和抗血小板治疗(P < .001)。
  • 非他汀组更常合并高凝状态(P = .009)或既往DVT(P = .033)。
  • 他汀组高风险PE更常见(P = .046),但两组血栓溶解、死亡率或VTE复发无差异。
  • 多变量分析中,他汀治疗、抗血小板治疗和年轻年龄与血栓溶解或改善相关。

临床怎么用

  • 对于DVT患者,他汀治疗可能促进血栓溶解,但未显示改善VTE复发或生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Statin therapy has been associated with a decreased incidence of venous thromboembolism (VTE) in clinical trials and enhanced thrombus resolution in animal models. The effect of statins on thrombus resolution has not been reported clinically. This study investigates the association of statins with thrombus resolution or improvement in patients with deep venous thrombosis (DVT). METHODS: A retrospective study of the electronic medical records of consecutive adult patients presenting with lower extremity DVT was performed. Patients were divided into two groups based on statin therapy (statin group) or lack thereof (nonstatin group). The two groups were compared with respect to demographics, comorbidities, and risk factors for VTE. Initial as well as all subsequent ultrasound reports were reviewed for each patient to determine extent of DVT and subsequent change in thrombus characteristics. Long-term outcomes examined were mortality, VTE recurrence, and thrombus improvement or resolution on follow-up ultrasound examination. Multivariable analysis was used to determine independent predictors of thrombus resolution or improvement, VTE recurrence, and mortality. RESULTS: A total of 818 patients with DVT were identified (statin group, n = 279 [34%]; nonstatin group, n = 539 [66%]). The patients in the statin group were significantly older (P < .001). Patients on statins were more likely to have risk factors for and manifestations of atherosclerosis and to be on antiplatelet therapy (P < .001), whereas those in the nonstatin group were more likely to have a hypercoagulable disorder (P = .009) or prior DVT (P = .033). There was no significant difference in provoked DVT, extent of DVT, or association with pulmonary embolism (PE), but patients on statins were more likely to have high-risk PE (P = .046). There was no difference in patients receiving anticoagulation, type and duration of anticoagulation, inferior vena cava filter placement, or treatment with lytic therapy. There was no difference in thrombus resolution, mortality, or recurrence of DVT, PE, or VTE between the groups. On multivariable analysis, age, proximal DVT, CAD, and cancer were associated with higher mortality, whereas anticoagulation with coumadin and direct oral anticoagulants and antiplatelet therapy were associated with lower mortality. Statin therapy, antiplatelet therapy, and younger age were associated with thrombus resolution or improvement. CONCLUSIONS: Statin therapy is associated with greater thrombus resolution or improvement in patients with DVT. However, statin therapy in this study was not associated with different clinical outcomes of VTE recurrence or mortality.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Hsu C, Brahmandam A, Brownson KE, et al. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 30660579. doi:10.1016/j.jvsv.2018.10.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。